BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17914004)

  • 21. Factors associated with psychotropic prescriptions, psychiatric hospitalization, and spending among Medicare beneficiaries under 65.
    Qian J; Wittayanukorn S; McGuffey G; Hansen R
    Disabil Health J; 2015 Jul; 8(3):424-33. PubMed ID: 25890881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Part D and dually eligible patients with mental illness: medication access problems and use of intensive services.
    Huskamp HA; West JC; Rae DS; Rubio-Stipec M; Regier DA; Frank RG
    Psychiatr Serv; 2009 Sep; 60(9):1169-74. PubMed ID: 19723730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicare Part D formulary coverage since program inception: are beneficiaries choosing wisely?
    Jackson EA; Axelsen KJ
    Am J Manag Care; 2008 Nov; 14(11 Suppl):SP29-35. PubMed ID: 18991478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
    J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increases in Medicare prescription drug plan costs attributable to psychotropic medications.
    Zivin K; McCammon RJ; Davis MM; Halasyamani LK; Kales HC
    Am J Geriatr Psychiatry; 2008 Aug; 16(8):674-85. PubMed ID: 18669946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State payment limitations on Medicare cost-sharing: impact on dually eligible beneficiaries.
    Mitchell JB; Haber SG
    Inquiry; 2004-2005 Winter; 41(4):391-400. PubMed ID: 15835598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suicidality is associated with medication access problems in publicly insured psychiatric patients.
    MoĊ›cicki EK; West JC; Rae DS; Rubio-Stipec M; Wilk JE; Regier DA
    J Clin Psychiatry; 2010 Dec; 71(12):1657-63. PubMed ID: 21190639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Medicare advantage payments on dually eligible Medicare beneficiaries.
    Atherly A; Dowd BE
    Health Care Financ Rev; 2005; 26(3):93-104. PubMed ID: 17290630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
    Morden NE; Garrison LP
    Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Medicare Part D coverage gap: implications for non-dually eligible older adults with a mental illness.
    Bakk L; Woodward AT; Dunkle RE
    J Gerontol Soc Work; 2014; 57(1):37-51. PubMed ID: 24377835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region.
    Chinthammit C; Bhattacharjee S; Axon DR; Slack M; Bentley JP; Warholak TL; Wilson DL; Lo-Ciganic WH
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1309-1316. PubMed ID: 32996396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS; Tirado B; Patel BV; Rein PJ
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eligibility For And Enrollment In Medicare Part D Medication Therapy Management Programs Varies By Plan Sponsor.
    Stuart B; Hendrick FB; Shen X; Dai M; Tom SE; Dougherty JS; Miller LM
    Health Aff (Millwood); 2016 Sep; 35(9):1572-80. PubMed ID: 27605635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health status of dually eligible beneficiaries in managed care plans.
    Lied TR; Haffer SC
    Health Care Financ Rev; 2004; 25(4):59-74. PubMed ID: 15493444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicaid beneficiaries using mental health or substance abuse services in fee-for-service plans in 13 states, 2003.
    Ireys HT; Barrett AL; Buck JA; Croghan TW; Au M; Teich JL
    Psychiatr Serv; 2010 Sep; 61(9):871-7. PubMed ID: 20810584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spending differences associated with the Medicare Physician Group Practice Demonstration.
    Colla CH; Wennberg DE; Meara E; Skinner JS; Gottlieb D; Lewis VA; Snyder CM; Fisher ES
    JAMA; 2012 Sep; 308(10):1015-23. PubMed ID: 22968890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.
    Kennedy J; Tuleu I; Mackay K
    J Manag Care Pharm; 2008; 14(6):553-60. PubMed ID: 18693779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.